AVA-NP-695, a potent and selective ENPP1 inhibitor, abrogates tumor metastasis in 4T1 syngeneic tumor model and demonstrates strong tumor regression when combined with radiation

paclitaxel - Generic mfg.

AVA-NP-695 - Avammune

Lynparza (olaparib) - Merck (MSD), AstraZeneca

Aditya Kulkarni1; Avijit Goswami2; Sandeep Goyal2; Princy Khurana2; Ishani Ghoshal2

Mar 14, 2023